Please ensure Javascript is enabled for purposes of website accessibility

An Altria-Philip Morris Merger Is Still a Possibility

By Rich Duprey - Jan 25, 2020 at 11:29AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

But it likely wouldn't happen soon.

Amid growing scrutiny over Altria's (MO 1.32%) investment in leading electronic cigarette manufacturer Juul Labs, global tobacco giant Philip Morris International (PM 1.42%) squashed the idea of merging the two cigarette companies.

Philip Morris CEO Andre Calantzopoulos said the two companies were better off concentrating solely on distributing Philip Morris' IQOS heated tobacco device. It is the only e-cig to receive FDA marketing approval, and Altria has the rights to market, distribute, and sell the device in the U.S. "After much deliberation, the companies have agreed to focus on launching IQOS in the U.S. as part of their mutual interest to achieve a smoke-free future,” Calantzopoulos was quoted as saying in a press release.

But Bloomberg earlier this week reported that the two might not have totally written off the idea of a union. At a gathering of global political and business leaders in Davos, Switzerland, Philip Morris COO Jacek Olczak reportedly said in answer to a question about whether Philip Morris would revisit the idea of merger, "the chapter is closed, but not the book."

Man breaking a cigarette

Image source: Getty Images.

Still mired in muck

It's not likely investors will see any action right away, however, as Altria is still trying to untangle regulatory umbrage over its $12.8 billion investment in Juul. 

More than a year after taking a 35% stake in the e-cig maker, the Federal Trade Commission still has not signed off on the deal. Adding to the probes already underway over the investment and the way that Juul has marketed its devices to teens, there's also concern over what, if any, influence Altria exerted in the resignation of Juul's CEO and having one of its own former executives inserted in his place.

The Wall Street Journal recently reported that the FTC is still investigating antitrust issues stemming from the transaction, looking closely at retail shelf space Altria acquired for e-cigs despite winding down its own MarkTen e-cig business. That shelf space was subsequently given to Juul.

Other opportunities are on the horizon

Yet Philip Morris apparently still sees the value of joining the two companies together. Because Altria and Philip Morris International were once one company, and the Marlboro brand is common to both -- Altria sells it in the U.S., Philip Morris sells it to the rest of the world -- there would indeed be efficiencies that could be realized.

Calantzopoulos told Bloomberg he sees consolidation in the e-cig industry's future, and that is undoubtedly true as the FDA's deadline for electronic cigarette companies to submit pre-market tobacco product applications is fast approaching and few e-cig manufacturers will be able to meet the high hurdle the FDA has set by themselves. So far, only Philip Morris and British American Tobacco have had the resources to file their applications, and have done so at great expense. For those companies unable to comply, their products will be pulled from the market, giving the biggest players a chance to scoop them up at significant discounts.

Bigger and better

Calantzopoulos says Philip Morris wants to be the e-cig leader with its IQOS device, and is getting ready to launch a new version called IQOS Mesh. The device uses a metallic mesh to heat a pre-filled, pre-sealed "cap" containing an e-liquid. Called VEEV, the caps contain nicotine, flavors, and a heater. 

Because they're all self-contained and produced by Philip Morris, they solve the problem of third parties concocting e-liquids that may contain harmful additives. The CDC says an outbreak last summer that saw thousands of vapers injured and dozens killed from lung injuries is likely linked to "tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, products, particularly from informal sources like friends, family, or in-person or online dealers." So a closed system has benefits.

Although keeping Altria and Philip Morris separate made sense for a lot of investors, as it gave them the choice of whether they wanted to be exposed to the litigious U.S. tobacco market, there are good arguments to be made for joining them together again.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Altria Group, Inc. Stock Quote
Altria Group, Inc.
$53.74 (1.32%) $0.70
Philip Morris International Inc. Stock Quote
Philip Morris International Inc.
$105.91 (1.42%) $1.48

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.